Antibiogram testing of pediatric skin infections in the era of methicillin-resistant Staphylococci aureus: An Egyptian University Hospital-based study

International Journal of Dermatology

Volumn 51, Issue 12, 2012, Pages 1441-1447

  Abdel Fattah, Nermeen S A ^a   Darwish, Yasser W ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFOXITIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; OXACILLIN; OXYTETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; CROSS-SECTIONAL STUDY; EGYPT; GROUP A STREPTOCOCCAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PRESCHOOL CHILD; SCHOOL CHILD; SECONDARY INFECTION; SKIN INFECTION; STREPTOCOCCUS GROUP A; UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CHILD; CHILD, PRESCHOOL; CLINDAMYCIN; CROSS-SECTIONAL STUDIES; EGYPT; ERYTHROMYCIN; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; IMPETIGO; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; OUTPATIENT CLINICS, HOSPITAL; POPULATION SURVEILLANCE; PREVALENCE; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 84869881925     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2012.05515.x     Document Type: Article

References (21)

1. Brown DFG, Edwards DI, Hawkey PM, et al. Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J Antimicrob Chemother 2005; 56: 1000-1018.
2. Hussain F, Boyle-Vavra S, Bethel CD, et al. Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility. Pedriatr Infect Dis J 2000; 19: 1163-1166.
3. Centers for Disease Control and Prevention. Community associated MRSA. Information from the US Centers for Disease Control and Prevention, 2010. http://www.cdc.gov/MRSA [Accessed August 10, 2010.]
4. Ortega-Loayza AG, Diamanti SA, Gilligan P, et al. Characterization of Staphylococcus aureus cutaneous infections in a pediatric dermatology tertiary health care outpatient facility. J Am Acad Dermatol 2010; 62: 804-811.
5. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005; 40: 1785-1791.
6. Collee JG, Miles RS, Watt B. Tests for identification of bacteria. In: Collee JG, Fraser AG, Marion BP, Simmons A, eds. Mackie and McCartney Practical Medical Microbiology, 14th edn. Cruckshank: Churchill-Livingstone, 1996: 133-150.
7. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Approved Standard M100-S17. Wayne, PA: Clinical and Laboratory Standards Institute, 2007.
8. Fiebelkorn KR, Crawford SA, McElmeel ML, et al. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol 2003; 41: 4740-4744.
9. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298: 1763-1771.
10. Gonzalez BE, Martinez-Aguilar G, Hulten KG, et al. Severe staphylococcal sepsis in adolescents in the era of community acquired methicillin-resistant Staphylococcus aureus. Pediatrics 2005; 115: 642-648.
11. Darmstadt GL. Oral antibiotic therapy for uncomplicated bacterial skin infections in children. Pediatr Infect Dis J 1997; 16: 227-240.
12. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005; 41: 1373-1406.
13. Hedrick J. Acute bacterial skin infections in pediatric medicine: current issues in presentation and treatment. Paediatr Drugs 2003; 5: 35-46.
14. Rybak MJ, LaPlante KL. Community associated methicillin-resistant Staphylococcus aureus: a review. Pharmacotherapy 2005; 25: 74-85.
15. Strom BL, Schinnar R, Apter AJ, et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med 2003; 349: 1628-1635.
16. Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Infect Control 2006; 34: S3-S10.
17. Mueller SC, Henkel KO, Neumann J, et al. Perioperative antibiotic prophylaxis in maxillofacial surgery: penetration of clindamycin into various tissues. J Craniomaxillofac Surg 1999; 27: 172-176.
18. Mascellino MT, Catania S, De Vito ML, et al. Erythromycin, miocamycin and clindamycin towards adhesivity and phagocytosis of gram-positive bacteria. Microbiologica 1988; 11: 231-241.
19. Frei CR, Miller ML, Lewis JS, et al. Retrospective cohort study of hospitalized adults treated with vancomycin or clindamycin for methicillin-resistant Staphylococcus aureus skin infections. Clin Ther 2010; 32: 2024-2029.
20. Siberry GK, Tekle T, Carroll K, et al. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis 2003; 37: 1257-1260.
21. Wu D, Wang Q, Yang Y, et al. Epidemiology and molecular characteristics of community-associated methicillin-resistant and methicillin-susceptible Staphylococcus aureus from skin/soft tissue infections in a children's hospital in Beijing, China. Diagn Microbiol Infect Dis 2010; 67: 1-8.